688566 Stock Overview
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Jiangsu Jibeier Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.85 |
| 52 Week High | CN¥32.41 |
| 52 Week Low | CN¥17.49 |
| Beta | 0.43 |
| 11 Month Change | -5.17% |
| 3 Month Change | 16.23% |
| 1 Year Change | -17.90% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688566 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.6% | -1.4% | -2.0% |
| 1Y | -17.9% | -6.0% | 4.6% |
Return vs Industry: 688566 underperformed the CN Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 688566 underperformed the CN Market which returned 2% over the past year.
Price Volatility
| 688566 volatility | |
|---|---|
| 688566 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688566 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688566's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,295 | Zhongyi Geng | www.jbepharm.com |
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. The company’s products cover various therapeutic areas, such as improving white blood cells, anti-hypertension, enhancing immunity, treating joint diseases, anti-eye infection, treating bronchitis, protecting liver function, and other therapeutic fields. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases.
Jiangsu Jibeier Pharmaceutical Co., Ltd. Fundamentals Summary
| 688566 fundamental statistics | |
|---|---|
| Market cap | CN¥4.76b |
| Earnings (TTM) | CN¥238.58m |
| Revenue (TTM) | CN¥887.17m |
19.9x
P/E Ratio5.4x
P/S RatioIs 688566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688566 income statement (TTM) | |
|---|---|
| Revenue | CN¥887.17m |
| Cost of Revenue | CN¥96.07m |
| Gross Profit | CN¥791.10m |
| Other Expenses | CN¥552.52m |
| Earnings | CN¥238.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 89.17% |
| Net Profit Margin | 26.89% |
| Debt/Equity Ratio | 0.1% |
How did 688566 perform over the long term?
See historical performance and comparison